Preclinical Studies of DA—125, a New Anthracycline Anticancer Agent
نویسندگان
چکیده
منابع مشابه
Fucoidan as a Marine Anticancer Agent in Preclinical Development
Fucoidan is a fucose-containing sulfated polysaccharide derived from brown seaweeds, crude extracts of which are commercially available as nutritional supplements. Recent studies have demonstrated antiproliferative, antiangiogenic, and anticancer properties of fucoidan in vitro. Accordingly, the anticancer effects of fucoidan have been shown to vary depending on its structure, while it can targ...
متن کاملPreclinical Screening for New Anticancer Agents
Cancer chemotherapy is a rather young discipline. It has been pursued with scientific vigor and multinational collaborations only since the mid-20th century. Although 92 approved anticancer drugs are available today for the treatment of more than 200 different tumor entities, effective therapies for most of these tumors are lacking (1). Out of the 92 registered drugs, 17 are considered by oncol...
متن کاملChronic cardiotoxicity studies in rabbits with 7-con-O-methylnogarol, a new anthracycline antitumor agent.
7-con-O-Methylnogarol (7-OMEN), a new analog of the an thracycline antibiotic, nogalamycin, has chemotherapeutic ac tivity in several experimental mouse tumor systems. As part of the preclinical development of 7-OMEN, the cardiotoxic poten tial was evaluated in chronically dosed rabbits. Groups of 4 rabbits were dosed twice weekly i.v. with 11 or 33 mg/sq m/ week for 12 weeks, 110 sq m/mg/week ...
متن کاملPodophyllotoxin: a novel potential natural anticancer agent
Objective: The aim of the present review is to give an overview about the role, biosynthesis, and characteristics of Podophyllotoxin (PTOX) as a potential antitumor agent with particular emphasis on key biosynthesis processes, function of related enzymes and characterization of genes encoding the enzymes. Materials and Methods: Google scholar, PubMed and Scopus were searched for literatures wh...
متن کاملTotect: a new agent for treating anthracycline extravasation.
Anthracycline chemotherapy agents bind to DNA and cause cell death when they extravasate into healthy tissue. Although many approaches to managing extravasations have been studied and reported, data from two prospective clinical trials suggest that Totect (dexrazoxane for injection, TopoTarget USA, Inc.) is an effective anthracycline extravasation treatment. Only 1 of 54 patients with doxorubic...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Korean Society for Clinical Pharmacology and Therapeutics
سال: 1994
ISSN: 1225-5467
DOI: 10.12793/jkscpt.1994.2.1.73